Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design is a research paper published in Neuro-Oncology Advances (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: R01 FD-R-07288
National Institutes of Health
Grant: 3UL1TR002377-04S5
Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Regan Theiler)
National Institutes of Health
Grant: 5R01FD007288-02
Phase I study to evaluate safety, tolerability, pharmacokinetics and anti-tumor activity of WSD0922-FU
FWCI
1.41
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals